Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 34 peer-reviewed journal articles Updated
Gastroenterology

The Biology and Causes of Chronic Pancreatitis

At a Glance

Chronic pancreatitis develops when repeated or ongoing injury causes inflammation and permanent scarring in the pancreas. Contributors include alcohol, smoking, genetic susceptibility, autoimmune disease, repeated acute attacks, or duct blockage, although the cause sometimes remains unknown.

While a diagnosis of Chronic Pancreatitis (CP) describes the state of your pancreas, understanding how it happened and why it continues is the key to managing it. The disease is not just a single event; it is a complex biological process that often involves multiple underlying causes working together.

The Biology of Damage: From Injury to Scarring

The pancreas is a delicate organ with three primary cell types involved in its main functions: acinar cells, which produce digestive enzymes, duct cells, which transport those enzymes to the small intestine, and endocrine islet cells, which produce hormones like insulin and glucagon [1][2].

In a simplified model of the disease, enzymes like trypsin are kept in an inactive form until they reach the gut. If they activate too early inside the pancreas—a process called trypsin autoactivation—they begin to digest the organ itself [3][4].

This internal “self-digestion” triggers a cascade of biological events:

  1. Acinar Cell Injury: Stress from alcohol, smoking, or genetic factors damages the cells’ internal machinery (the endoplasmic reticulum and mitochondria) [3].
  2. Inflammation: Damaged cells release “danger signals” that alert the immune system, causing persistent inflammation [5][6].
  3. Stellate Cell Activation: Normally, pancreatic stellate cells stay quiet and store vitamin A. When they sense injury or inflammation, they “wake up” and turn into myofibroblasts—cells that produce tough, fibrous scar tissue [7][8].
  4. Fibrosis and Atrophy: As these cells deposit more scar tissue (fibrosis), the healthy, functional parts of the pancreas begin to shrink (atrophy) [1][9]. This eventually leads to calcifications (calcium stones) and permanent damage to the organ’s ability to produce enzymes and insulin [1][10]. (Note that not every patient develops every structural feature.)

The TIGAR-O Framework: Finding the Root Cause

Doctors use a system called TIGAR-O to organize the many different risk factors that can lead to chronic pancreatitis [11]. It is important to know that TIGAR-O is not a score of how “bad” your disease is, nor does it prove causation; rather, it is a checklist of possible contributors to help your team tailor your care [11][12]. Many patients have factors from more than one category, and some never identify a single cause [13].

  • T (Toxic-metabolic): This includes external stressors like alcohol and tobacco smoking, as well as internal issues like very high blood calcium (hypercalcemia) or high fats in the blood (hypertriglyceridemia) [14][13].
  • I (Idiopathic): This label is used when the cause is not yet known. It is often divided into “early-onset” (starting in childhood or young adulthood) and “late-onset” (starting after age 35) [11][15].
  • G (Genetic): This refers to inherited mutations that make the pancreas more vulnerable to injury (see the Genetics section below) [16][11].
  • A (Autoimmune): A specific form of the disease where the immune system mistakenly attacks the pancreas. Autoimmune Pancreatitis (AIP) requires specialist confirmation and exclusion of malignancy before steroid treatment [17][18].
  • R (Recurrent/Severe Acute): Repeated attacks of Acute Pancreatitis can eventually lead to permanent damage and CP over time [19][20].
  • O (Obstructive): Physical blockages, such as a scarred pancreatic duct, a tumor, or a birth variation like pancreas divisum (which is common and often incidental, but can sometimes contribute to disease), can trap enzymes and cause damage [21][1].

The Role of Genetics

For many people, genetics do not “cause” pancreatitis on their own but rather lower the organ’s “threshold” for damage [22]. Because genetic results can be complex and involve uncertain variants, genetic counseling is strongly recommended before testing and when interpreting what the results mean for you and your family.

  • PRSS1: This is the “Hereditary Pancreatitis” gene. Pathogenic variants in PRSS1 can cause hereditary pancreatitis, but the penetrance is variable, meaning not everyone with the variant will develop the disease [23][24].
  • SPINK1: The SPINK1 protein acts like a “safety cap” for the pancreas, neutralizing small amounts of active trypsin before they can cause harm [25]. Variants in this gene are often susceptibility modifiers rather than definitive causes [25][26].
  • CFTR: While severe mutations in this gene cause Cystic Fibrosis, milder variants can impair how the pancreatic ducts secrete bicarbonate and fluids, acting as disease modifiers [27][28].
  • CTRC: This gene helps the body break down and dispose of misplaced trypsin. Variants in CTRC reduce this protective effect, acting as a “disease modifier” that can make other risk factors more dangerous [22][29].

Look-Alike Conditions

Because the symptoms of chronic pancreatitis (like pain and weight loss) are common to many digestive issues, doctors must rule out other conditions:

  • Pancreatic Cancer: A tumor can block the pancreatic duct and cause inflammation that looks like CP. Specialist imaging (like EUS or MRCP) is often needed to tell the difference [30][31].
  • Peptic Ulcers or Gallstones: These can cause similar upper abdominal pain but require very different treatments [32].
  • Functional Dyspepsia: This is a condition where the digestive tract doesn’t function normally, causing pain and bloating without structural damage to the pancreas [33].
  • Celiac Disease: Difficulty absorbing nutrients can cause the same oily stools and weight loss seen in pancreatic insufficiency [34].

Common questions in this guide

What can lead to chronic pancreatitis?
Chronic pancreatitis can result from alcohol use, smoking, high blood calcium or triglycerides, inherited susceptibility, autoimmune disease, repeated acute pancreatitis, or a blocked pancreatic duct. More than one contributor may be present, and some people never have a single cause identified.
What is the TIGAR-O system used for?
The TIGAR-O framework is a checklist doctors use to organize possible contributors to chronic pancreatitis: toxic-metabolic factors, unknown causes, genetic factors, autoimmune disease, recurrent acute attacks, and obstruction. It is not a measure of disease severity and does not prove that one factor caused the condition.
Do genetic variants mean I will develop chronic pancreatitis?
Not necessarily. PRSS1 variants can cause hereditary pancreatitis, but not everyone with a disease-causing variant develops it, while SPINK1, CFTR, and CTRC variants often change susceptibility rather than determine the diagnosis. Genetic counseling can help explain testing and family implications.
How does pancreatic injury turn into chronic disease?
Early activation of digestive enzymes such as trypsin can injure the pancreas and trigger ongoing inflammation. Scar-forming pancreatic stellate cells can then produce fibrosis, which may cause shrinkage, calcifications, and reduced production of digestive enzymes and hormones such as insulin.
Could another condition be causing symptoms that look like chronic pancreatitis?
Yes. Pancreatic cancer, ulcers, gallstones, functional dyspepsia, and celiac disease can cause symptoms that overlap with chronic pancreatitis, such as abdominal pain, weight loss, or oily stools. Tests such as endoscopic ultrasound or magnetic resonance cholangiopancreatography may help specialists distinguish among these conditions.
How is autoimmune pancreatitis evaluated before steroid treatment?
Autoimmune pancreatitis needs confirmation by a specialist. Because pancreatic cancer can look similar, doctors should exclude malignancy before steroid treatment.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my imaging and history, which TIGAR-O categories do you think might be contributing to my pancreatitis?
  2. 2.Given my family history and age of onset, would you recommend genetic counseling for variants like PRSS1, SPINK1, or CFTR?
  3. 3.How do you differentiate my symptoms from other conditions like functional dyspepsia or autoimmune pancreatitis?
  4. 4.What specific structural changes, like duct dilation or calcifications, were visible on my recent scans?
  5. 5.If I have a genetic variant like SPINK1, does that change my treatment plan or how often I need to be screened for complications?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (34)
  1. 1

    Chronic pancreatitis: An international draft consensus proposal for a new mechanistic definition.

    Whitcomb DC, Frulloni L, Garg P, et al.

    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2016; (16(2)):218-24.

    PMID: 26924663
  2. 2

    Pancreatic Ductal Deletion of Hnf1b Disrupts Exocrine Homeostasis, Leads to Pancreatitis, and Facilitates Tumorigenesis.

    Quilichini E, Fabre M, Dirami T, et al.

    Cellular and molecular gastroenterology and hepatology 2019; (8(3)):487-511 doi:10.1016/j.jcmgh.2019.06.005.

    PMID: 31229598
  3. 3

    Acute Pancreatitis: A Multifaceted Set of Organelle and Cellular Interactions.

    Habtezion A, Gukovskaya AS, Pandol SJ

    Gastroenterology 2019; (156(7)):1941-1950 doi:10.1053/j.gastro.2018.11.082.

    PMID: 30660726
  4. 4

    Early trypsin activation develops independently of autophagy in caerulein-induced pancreatitis in mice.

    Malla SR, Krueger B, Wartmann T, et al.

    Cellular and molecular life sciences : CMLS 2020; (77(9)):1811-1825 doi:10.1007/s00018-019-03254-7.

    PMID: 31363815
  5. 5

    HMGB1 contributes to pancreatic fibrosis by regulating TLR4-mediated autophagy and the NLRP3 inflammasome pathway in chronic pancreatitis.

    Li C, Cui L, Zuo Y, et al.

    Experimental cell research 2025; (452(1)):114745 doi:10.1016/j.yexcr.2025.114745.

    PMID: 40915340
  6. 6

    The effects of nuclear factor-kappa B in pancreatic stellate cells on inflammation and fibrosis of chronic pancreatitis.

    Wu N, Xu XF, Xin JQ, et al.

    Journal of cellular and molecular medicine 2021; (25(4)):2213-2227 doi:10.1111/jcmm.16213.

    PMID: 33377616
  7. 7

    Activation and Regulation of Pancreatic Stellate Cells in Chronic Pancreatic Fibrosis: A Potential Therapeutic Approach for Chronic Pancreatitis.

    Kong F, Pan Y, Wu D

    Biomedicines 2024; (12(1)) doi:10.3390/biomedicines12010108.

    PMID: 38255213
  8. 8

    IL11 Activates Pancreatic Stellate Cells and Causes Pancreatic Inflammation, Fibrosis and Atrophy in a Mouse Model of Pancreatitis.

    Ng B, Viswanathan S, Widjaja AA, et al.

    International journal of molecular sciences 2022; (23(7)) doi:10.3390/ijms23073549.

    PMID: 35408908
  9. 9

    Chronic pancreatitis.

    Kleeff J, Whitcomb DC, Shimosegawa T, et al.

    Nature reviews. Disease primers 2017; (3()):17060 doi:10.1038/nrdp.2017.60.

    PMID: 28880010
  10. 10

    Low serum trypsinogen levels in chronic pancreatitis: Correlation with parenchymal loss, exocrine pancreatic insufficiency, and diabetes but not CT-based cambridge severity scores for fibrosis.

    Zhan W, Akshintala V, Greer PJ, et al.

    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2020; (20(7)):1368-1378 doi:10.1016/j.pan.2020.08.025.

    PMID: 32967795
  11. 11

    Pancreatitis: TIGAR-O Version 2 Risk/Etiology Checklist With Topic Reviews, Updates, and Use Primers.

    Whitcomb DC,

    Clinical and translational gastroenterology 2019; (10(6)):e00027 doi:10.14309/ctg.0000000000000027.

    PMID: 31166201
  12. 12

    Understanding the Pathophysiology of Chronic Pancreatitis: A Comprehensive Review Unraveling Pain Mechanisms and the Role of Psychosocial Factors.

    Sekhar AC, Kandhi S, Ramaswamy P, et al.

    Journal of clinical medicine 2026; (15(10)) doi:10.3390/jcm15103831.

    PMID: 42194791
  13. 13

    Validation of Demographics, Etiology, and Risk Factors for Chronic Pancreatitis in the USA: A Report of the North American Pancreas Study (NAPS) Group.

    Conwell DL, Banks PA, Sandhu BS, et al.

    Digestive diseases and sciences 2017; (62(8)):2133-2140 doi:10.1007/s10620-017-4621-z.

    PMID: 28600657
  14. 14

    Smoking as the most important risk factor for chronic pancreatitis in the general population.

    Hansen SEJ, Nordestgaard BG, Langsted A

    European journal of epidemiology 2023; (38(1)):95-107 doi:10.1007/s10654-022-00945-7.

    PMID: 36593333
  15. 15

    Multiple Correspondence Analysis reveals two different phenotypes of idiopathic chronic pancreatitis.

    Guilabert L, Maisonneuve P, Deli C, et al.

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2026; (58(8)):1090-1096 doi:10.1016/j.dld.2026.05.012.

    PMID: 42297698
  16. 16

    Chronic pancreatitis: review and update of etiology, risk factors, and management.

    Pham A, Forsmark C

    F1000Research 2018; (7()) doi:10.12688/f1000research.12852.1.

    PMID: 29946424
  17. 17

    Autoimmune pancreatitis: Cornerstones and future perspectives.

    Gallo C, Dispinzieri G, Zucchini N, et al.

    World journal of gastroenterology 2024; (30(8)):817-832 doi:10.3748/wjg.v30.i8.817.

    PMID: 38516247
  18. 18

    Sialadenitis in a patient with ulcerative colitis and autoimmune pancreatitis type 2.

    Detlefsen S, Olesen SS

    Pathology, research and practice 2020; (216(9)):153072 doi:10.1016/j.prp.2020.153072.

    PMID: 32825945
  19. 19

    Imaging of inflammatory disease of the pancreas.

    Bastati N, Kristic A, Poetter-Lang S, et al.

    The British journal of radiology 2021; (94(1123)):20201214 doi:10.1259/bjr.20201214.

    PMID: 34111970
  20. 20

    [Chronic pancreatitis : Characterization and differentiation from pancreatic cancer].

    Kristic A, Bastati N, Poetter-Lang S, et al.

    Der Radiologe 2021; (61(6)):563-571 doi:10.1007/s00117-021-00857-9.

    PMID: 34002282
  21. 21

    Piezo1-mediated stellate cell activation causes pressure-induced pancreatic fibrosis in mice.

    Swain SM, Romac JM, Vigna SR, Liddle RA

    JCI insight 2022; (7(8)).

    PMID: 35451372
  22. 22

    Mesotrypsin Signature Mutation in a Chymotrypsin C (CTRC) Variant Associated with Chronic Pancreatitis.

    Szabó A, Ludwig M, Hegyi E, et al.

    The Journal of biological chemistry 2015; (290(28)):17282-92 doi:10.1074/jbc.M114.618439.

    PMID: 26013824
  23. 23

    Hereditary Pancreatitis Associated With the N29T Mutation of the PRSS1 Gene in a Brazilian Family: A Case-Control Study.

    Dytz MG, Mendes de Melo J, de Castro Santos O, et al.

    Medicine 2015; (94(37)):e1508 doi:10.1097/MD.0000000000001508.

    PMID: 26376395
  24. 24

    Misfolding PRSS1 variant p.Ala61Val in a case of suspected intrauterine pancreatitis.

    Sándor M, Vitale DS, Nagy ZA, et al.

    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2025; (25(1)):70-81 doi:10.1016/j.pan.2024.12.013.

    PMID: 39734120
  25. 25

    SPINK1-related chronic pancreatitis: A model that encapsulates the spectrum of variant effects, genetic complexity, and classificatory challenges.

    Wang YC, Masson E, Wang QW, et al.

    American journal of human genetics 2025; (112(9)):2043-2066 doi:10.1016/j.ajhg.2025.07.013.

    PMID: 40845847
  26. 26

    Defective binding of SPINK1 variants is an uncommon mechanism for impaired trypsin inhibition in chronic pancreatitis.

    Szabó A, Toldi V, Gazda LD, et al.

    The Journal of biological chemistry 2021; (296()):100343 doi:10.1016/j.jbc.2021.100343.

    PMID: 33515547
  27. 27

    Bicarbonate defective CFTR variants increase risk for chronic pancreatitis: A meta-analysis.

    Berke G, Gede N, Szadai L, et al.

    PloS one 2022; (17(10)):e0276397 doi:10.1371/journal.pone.0276397.

    PMID: 36264955
  28. 28

    Expanding ACMG variant classification guidelines into a general framework.

    Masson E, Zou WB, Génin E, et al.

    Human genomics 2022; (16(1)):31 doi:10.1186/s40246-022-00407-x.

    PMID: 35974416
  29. 29

    The Common Chymotrypsinogen C (CTRC) Variant G60G (C.180T) Increases Risk of Chronic Pancreatitis But Not Recurrent Acute Pancreatitis in a North American Population.

    LaRusch J, Lozano-Leon A, Stello K, et al.

    Clinical and translational gastroenterology 2015; (6()):e68 doi:10.1038/ctg.2014.13.

    PMID: 25569187
  30. 30

    Pancreatic Cancer and Its Mimics.

    Miller FH, Lopes Vendrami C, Hammond NA, et al.

    Radiographics : a review publication of the Radiological Society of North America, Inc 2023; (43(11)):e230054 doi:10.1148/rg.230054.

    PMID: 37824413
  31. 31

    Pancreatitis and PDAC: association and differentiation.

    Elsherif SB, Virarkar M, Javadi S, et al.

    Abdominal radiology (New York) 2020; (45(5)):1324-1337 doi:10.1007/s00261-019-02292-w.

    PMID: 31705251
  32. 32

    Guidelines for the Diagnostic Cross Sectional Imaging and Severity Scoring of Chronic Pancreatitis.

    Frøkjær JB, Akisik F, Farooq A, et al.

    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2018; (18(7)):764-773 doi:10.1016/j.pan.2018.08.012.

    PMID: 30177434
  33. 33

    Radiomics and Its Applications and Progress in Pancreatitis: A Current State of the Art Review.

    Yan G, Yan G, Li H, et al.

    Frontiers in medicine 2022; (9()):922299 doi:10.3389/fmed.2022.922299.

    PMID: 35814756
  34. 34

    Qualitative Assessment of the Symptoms and Impact of Pancreatic Exocrine Insufficiency (PEI) to Inform the Development of a Patient-Reported Outcome (PRO) Instrument.

    Johnson CD, Arbuckle R, Bonner N, et al.

    The patient 2017; (10(5)):615-628 doi:10.1007/s40271-017-0233-0.

    PMID: 28332032

This page explains how chronic pancreatitis develops and how doctors investigate possible causes for informational purposes only; it does not replace medical advice. Discuss genetic testing, imaging findings, and treatment decisions with your gastroenterology team.

Get notified when new evidence is published on chronic pancreatitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.